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G1, G2, G3, G4 Histologic grade of tumours
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83. INTRODUCTION
The basement membrane (BM) separates epithelial elements from the surrounding
stroma (Adams and Watt, 1993; Merker, 1994). Recently, the dynamic role of the
BM in regulation of epithelial cells differentiation as well as their organization into
three dimensional tissues has become better understood. In these functions, among
the molecules of the BM, laminins have been noted to be especially dynamic
(Aumailley and Smyth, 1998). Laminins are a growing family of trimeric
macromolecules located in the BM. Interactions of laminins with cells have been
especially widely studied in epithelial cells (Ekblom et al., 1998). The spatially and
temporally regulated distribution of various laminin chains in epithelial tissues
reflects their important role in cellular functions (Ekblom et al., 1996; 1998;
Engvall, 1993). The functions of laminins are transduced via cell surface receptors,
the most important of which are heterodimeric integrin molecules (Aumailley et
al., 1996; Sheppard, 1996).
Carcinomas are malignancies derived from epithelial cells. In the progression of
carcinomas, the role of the BM and laminins is not well understood. The BM has
been thought to act as a barrier against carcinoma cell invasion (Barsky et al.,
1983; Bosman, 1994; Flug and Köpf-Maier, 1995). On the other hand, proliferation
of carcinoma cells may be promoted via adhesion to BM molecules; BM laminins
in particular may play a role in enhancing carcinoma cell motility (Miyazaki et al.,
1993; Pyke et al., 1994; 1995; Tani et al., 1997; Xia et al., 1996).
In this work, the distribution of different laminin isoforms was studied in
developing and mature thyroid gland and colorecal mucosa as well as in renal,
thyroid, and colorectal neoplastic tissues. Furthermore, the distribution of laminins
was compared to the distribution of their integrin receptors. The production of
laminin by carcinoma cells in vitro and in vivo conditions was also investigated as
well as the role of integrins in the adhesion of carcinoma cells to laminins.
94. REVIEW OF THE LITERATURE
4.1 EXTRACELLULAR MATRIX
Cells are surrounded by extracellular matrix (ECM), which has important
interactions with cells. ECM acts as a mechanical scaffold for cells and influences
such functions as cell proliferation, differentiation, adhesion, migration, gene
expression, and tissue integrity (Adams and Watt, 1993; Hagios et al., 1998). ECM
is composed of many composite structures which determine the architecture
specific to every organ as well as the developmental stage of that organ. Various
ECM molecules and their macromolecular polymeric forms regulate the functional
activity of ECM (Aumailley and Gayraud, 1998). ECM may be divided into the
interstitial matrix and a densified protein layer called the BM. The structural
molecules of the interstitial matrix contain various collagens, fibronectins,
vitronectin, tenascins, elastins, fibrillins, and proteoglycans (Merker, 1994). The
major BM molecules are laminins, type IV collagens, and nidogen as well as some
proteoglycans and the more variable components of BM, including type VII
collagen (Yurchenco and O´Rear, 1994).
4.2 BASEMENT MEMBRANE
4.2.1 STRUCTURE OF THE BASEMENT MEMBRANE
The existence of the BM (Fig. 1) has been known since the eighteenth century,
when it was described as a demarcating layer between tissue compartments based
on its refractive properties (see Merker, 1994). Later, histochemical techniques:
immunohistochemistry and in situ hybridization, have given more detail
information about the localization, composition and production of BM constituents
(Leblond and Inoue, 1989). Electron microscopy has generated information on BM
structural organization (Flug and Köpf-Maier, 1995; Inoue, 1997; Merker, 1994).
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Fig. 1. Electron microscopic picture of underarm skin of the author. The
lamina densa of the BM (long arrows) is a continuous, electron-dense layer
of proteins. Hemidesmosomes (medium-sized arrows) are electron-dense
plaques on the basal side of keratinocytes. Cytokeratin fibrils are detectable
inside the cell (short arrows). Figure made by Tomi Leivo.
The BM demarcates connective tissue from epithelium. In addition, endothelium,
various types of muscle cell, lipocytes, and Schwann’s cells are surrounded by BM
(Merker, 1994). Epithelial BM is produced in co-operation between epithelial and
mesenchymal cells. (For original articles, see Hahn et al., 1987; Marinkovich et al.,
1993; Perreault et al., 1998; Simo et al., 1992; for review, see Simon-Assmann et
al., 1995) Based on electron microscopy, BM is divided into layers called the
lamina lucida, lamina densa, and lamina fibroreticularis according to their electron
density (Leblond and Inoue, 1989), but the existence of the lamina lucida has been
questioned by some investigators (Chan and Inoue, 1994). The lamina
fibroreticularis connects the lamina densa to the surrounding connective tissue and
contains extensions from the lamina densa. The extensions are called anchoring
fibrils and microfibrils containing type VII collagen and heparan sulfate
proteoglycan (Inoue, 1997; Merker, 1994).
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4.2.2 BIOLOGICAL FUNCTIONS OF THE BASEMENT MEMBRANE
The functions of BM in offering mechanical stability for cells and tissues has been
known since an early stage in the history of BM research (Merker, 1994). The
mechanical stability of BM itself is well exemplified in the skin as well as in
kidney glomeruli, i.e., the ability to resist high shearing forces at the dermal-
epidermal junction and resist considerable hydrostatic pressure in glomerular
capillaries (Timpl and Brown, 1996). The networks of type IV collagen, laminin
and nidogen, are important elements in serving the mechanical stability of BM
(Timpl, 1996).
Since the seventies, it has been thought that BM is a dynamic structure, and that it
is involved also in numerous biological processes, acting as a factor in maintaining
polarity and organization of epithelial cells (Adams and Watt, 1993; Engvall, 1993;
Flug and Köpf-Maier, 1995; Furness, 1997; Merker, 1994). Since the eighties, cell
and tissue culture studies, gene knock-out experiments, and genetic diseases have
provided more detailed information on the biological role of BM molecules
(Hynes, 1996). BM has been seen to be an active regulator in epithelial-
mesenchymal interactions during epithelial cell development (Ekblom et al., 1998).
BM molecules can regulate the activity of growth factors which, in turn, are
important regulators in epithelial cell differentiation and development (Taipale and
Keski-Oja, 1997). Experimental studies have shown that laminins are functional
molecules of  BM in regulation of epithelial cell development and differentiation
(Klein et al., 1988; for a reviews see, Adams and Watt, 1993; Engvall, 1993;
Ekblom et al., 1998).
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4.3 LAMININS
4.3.1 LAMININ TRIMERS
The first laminin trimer was isolated from a mouse tumour, the Engelbreth-Holm-
Swarm tumour, hence the name EHS-laminin (Chung et al., 1979; Timpl et al.,
1979). The chains of EHS-laminin were first called A, B1, and B2. EHS-laminin
has been renamed laminin-1 (Fig. 2) and the chains of laminin-1 named α1, β1,
and γ1 (Burgeson et al., 1994). Four long laminin α chains (α1, α2, α3B, α5) and
two short laminin α chain variants (splice variant α3A and, α4) have been
characterised (Galliano et al., 1995; Miner et al., 1997). Differentially numbered
laminin chains are the products of distinct genes (Miner et al., 1997). Three short
laminin β chain (β1-β3) and three short laminin γ chain (γ1-γ3) variants exist
(Koch et al., 1999; Timpl and Brown, 1996). Probably, all heterotrimeric laminin
combinations of these chains are not possible (Aumailley and Smyth, 1998).
Nowadays, they are presumed to assemble into at least twelve laminin isoforms
(laminin-1-12) (Burgeson et al., 1994; Koch et al., 1999; Timpl, 1996; Miner et al.,
1997). The composition of all known laminin trimers is shown in Table I.
Fig. 2. Molecular schema of laminin trimers 1, 10, and 5. Modified
from Durbeej-Hjalt et al., 1997.
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Table I. Chain composition of the known laminin trimers. (see, Burgeson et al.,
1994; Koch et al., 1999; Miner et al., 1997; Timpl and Brown, 1996)
Individual cells are able to produce several laminin chains simultaneously and
deposit them together in the BM. Distinct domains play a role in the formation of
the trimeric structure. The stability of the coiled-coil structures has been considered
to be determined by ionic interactions (Timpl and Brown, 1996). A capacity for
self-assembly has been demonstrated for laminins -1, -2 and -4, but not for
laminin-5 (Cheng et al., 1997).
4.3.2 LAMININ-5
Laminin-5 (Fig. 2) is a component of the epithelial cell adhesion complex
containing hemidesmosomes, anchoring fibrils, and anchoring fibers (Gerecke et
al., 1994). Laminin-5 connects the hemidesmosomes with the underlying
connective tissue through type VII collagen (Rousselle et al., 1997). Laminin-5 and
type VII collagen have earlier been considered to be specific for the BMs of
squamous and stratified epithelia (Gerecke et al., 1994; Leigh et al., 1987; Merker,
1994; Rousselle et al., 1991; Utani et al., 1995; Wetzels et al., 1991). The laminin-
5 isoform is complexed with the γ2 chain, which binds fibulin 2 (Utani et al.,
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1997). Laminin-5 is secreted as a high molecular weight precursor, and its α3 and
γ2 chains are post translationally processed by proteolysis (Marinkovich et al.,
1992). Laminin-5 chains lack some domains present in other laminin chains. The
laminin α3 chain is expressed in two alternatively spliced isoforms called α3A and
α3B (Ryan et al., 1994). These present distinctive expression patterns at least in
murine tissues. Laminin α3A is expressed especially in epidermis (Galliano et al.,
1995). Laminin-5 forms a rod-like structure with truncated short arms. The cell
adhesion promoting activity of laminin-5 is dependent on the coiled conformation
of the molecule (Aumailley et al., 1996).
4.3.3 LAMININ α2 AND α4 CHAINS
Laminin α2 and α4 chains have often been considered mesenchymal laminins. The
laminin α2 chain was originally found in the BMs of Schwann cells, striated
muscle, and trophoblast and it was named merosin (Leivo and Engvall, 1988).
Later, the laminin α2 chain was found in various developing and adult tissues,
including the kidney (Miner et al., 1997; Virtanen et al, 1995b), thyroid (Andre et
al., 1994; Serini et al., 1996), and gastrointestinal tract (Virtanen et al., 1995a;
Simon-Assmann et al., 1994; Perreault et al., 1995). The laminin α4 chain has been
found in various human and mouse tissues including intestine and kidney
(Iivanainen et al., 1995; Miner et al., 1997; Sorokin et al., 1997) and is synthesized
at least by endothelial cells (Sorokin et al., 1994).
4.3.4 BIOLOGICAL FUNCTIONS OF LAMININS
Laminins play a key role in several differentiation events such as myogenesis, and
in migration of nerve and mesenchymal cells as well as in endothelial
morphogenesis (Adams and Watt, 1993; Aumailley and Gayraud, 1998; Ekblom et
al., 1996, Engvall, 1993; Ryan et al., 1996). Most widely studied is the role of
laminins in epithelial cell differentiation. Klein et al., (1988) discovered a role for
laminin in epithelial cell polarization during morphogenesis of renal tubules. The
significance of laminin in the formation of kidney tubules was later suggested in
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organ culture experiments by Sorokin et al., (1992). Intestinal epithelial cell culture
studies have also suggested that laminin promotes the activity of brush-border
enzymes, alkaline phosphatase and lactase, which are markers of differentiation in
intestinal epithelial cells (Hahn et al., 1990). Toda et al. (1995) have revealed the
role of laminin in proliferation and differentiation of thyroid follicular epithelium.
Gene defects have also provided detailed information on the function of laminins
(For reviews, see Aumailley and Smyth, 1998; Ryan et al., 1996). Mutations in
genes encoding chains of laminin-5 are involved in pathogenesis of junctional
epidermolysis bullosa, leading to extensive blistering and erosion (see e.g.
Kivirikko et al., 1995; Matsui et al., 1998; Pulkkinen et al., 1994). This provides
evidence for the role of the laminin-5 isoform in providing stability for basal
keratinocytes. Gene knock-out mice for the laminin β2 chain suffered massive
proteinuria, suggesting its role in glomerular filtration (Noakes et al., 1995).
Mutations in the laminin α2 chain result in muscular dystrophy, suggesting its role
in muscular cell structure and function (see Allamand et al., 1997; Nissinen et al.,
1996).
4.4 OTHER BASEMENT MEMBRANE MOLECULES
Among other major BM molecules, collagen type IV is a helical, trimeric protein.
The most widely expressed type IV collagen trimer is composed of two α1(IV)
chains and one α2(IV) chain (Hudson et al., 1993). The α3(IV)-α6(IV) chains have
a more restricted tissue distribution, present for example in the kidney (Miner and
Sanes, 1994; Ninomiya et al., 1995; Lohi et al., 1997). The biological role of
various collagen IV chains/trimers is not well understood.
Nidogen is a 150 kD glycoprotein consisting of three globular domains (Timpl et
al., 1983; Dziadek, 1995). It binds collagen IV and laminin networks together
(Timpl, 1996). The high-affinity nidogen-binding site has been suggested to be
localised in the short arm of the laminin γ1 chain (Timpl and Brown, 1996). Hence,
nidogen may be able to bind all known laminin trimers except laminin-5
16
(Aumailley and Smyth, 1998). In addition to laminin and type IV collagen, nidogen
binds the BM constituents perlecan, fibulin-1, and fibulin-2 (Timpl and Brown,
1996).
Type VII collagen forms the anchoring fibrils in the lamina fibroreticularis, and
connects the BM lamina densa to the underlying connective tissue (Borradori and
Sonnenberg, 1996; Champliaud et al., 1996). Collagen type VII has a collagenous
triple helix and a noncollagenous domain, NC1, in the amino-terminus of the 3 α1
(VII) chains (Bruckner-Tuderman, 1991; Burgeson, 1993). Type VII collagen
binds, in addition to laminin-5, also type IV collagen (Burgeson, 1993). Mutations
in gene coding for type VII collagen lead to the dystrophic form of epidermolysis
bullosa (Järvikallio et al., 1997), suggesting the important role of type VII collagen
in providing mechanical stability for epidermal BM.
BM also contains various other components. Proteoglycans are ubiquitous BM
constituents. The most abundant proteoglycan, perlecan, is composed of core
protein and heparan sulfate or chondrotin sulfate chains (Timpl and Brown, 1996).
Tenascin-C, a modular protein expressed in multiple isoforms produced by
alternative splicing from a single gene, is located in the BM region of some tissues
(Erickson, 1993). Tenascin-C is composed of six monomers, joined together at
their amino terminal end by disulfide bonds (Chiquet-Ehrismann, 1995).
4.5 CELL ADHESION TO BASEMENT MEMBRANE
4.5.1 INTEGRINS
Cellular activities of laminins and other BM proteins are mediated by cell surface
receptors. Integrins are heterodimeric receptor proteins each composed of  an α and
a β subunit. At least 17 different α and 8 β integrin subunits are known (Sheppard,
1998; Streit et al., 1996; Varner and Cheresh, 1996). Each integrin subunit has a
large extracellular domain. The ligand binding site of integrins is in the
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extracellular region and is formed by both chains (Hynes, 1992; Clezardin, 1998).
The cytoplasmic domain of integrins, excluding the β4 subunit, is relatively short
(Aumailley et al., 1996). Integrins play a role in such functions as signal
transduction, gene expression, proliferation, apoptosis regulation and
embryogenesis (Albeda and Buck, 1990; Adams, 1997; Schwartz et al., 1995). The
cytoplasmic domain of integrin α and β subunits, which anchors the cytoskeleton
to the plasma membrane, is important in the signaling events (Dedhar and
Hannigan, 1996). Laminin is believed to provide a substratum for adhesion via
integrins α1β1, α2β1, α3β1, α6β1, α6β4, α7β1 and α9β1 (Ekblom et al., 1998; Timpl
and Brown, 1996). Among them, integrins α3β1 and α6β4 are potential receptors for
laminin-5 (Aumailley and Smyth, 1998; Carter et al., 1991; Delwel et al., 1994;
Xia et al., 1996). Additionally, integrin α2β1 has recently been suggested to play a
role in binding to laminin-5 (Orian-Rousseau et al., 1998). Gene defects in
integrins α6 and β4 cause a phenotype of epidermolysis bullosa and pyloric atresia
(Brown et al., 1996; Vidal et al., 1995), whereas a defect in integrin α3β1 leads to
severe disorganization of the BM (DiPersio et al., 1997; Kreidberg et al., 1996).
4.5.2 HEMIDESMOSOMES
Hemidesmosomes (Figs. 1 and 3) are small multiprotein complexes in the basal
cell surface of epithelial cells. The name hemidesmosome comes from their
resemblance under the electronic microscope to half of a desmosome (Jones et al.,
1998). Hemidesmosomes connect the elements of the cellular cytoskeleton to the
underlying BM. They are present at least in the basal layer of the stratified and
compound epithelia. Molecular constituents of hemidesmosomes include
transmembrane integrin α6β4 and bullous pemphigoid antigen 180 (BP 180, also
known as XVII collagen), as well as cytoplasmic BP 230 and HD1/plectin (Jones et
al., 1998). Inside the cell, the long cytoplasmic tail of integrin β4 binds
HD1/plectin, which links hemidesmosome with cytokeratins (Rezniczek et al.,
1998). The cytokeratins associated with hemidesmosomes are believed to be ck-5
and ck-14. Outside the cells, adhesion is mediated via laminin-5 and type VII
collagen (Borradori and Sonnenberg, 1996). Hemidesmosomes act in the signal
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transduction process via α6β4 integrin and regulate cellular activities such as gene
expression and cell proliferation and differentiation (Clarke et al., 1995; Jones et
al., 1998; Maniero et al., 1995).
In this study, I will use the term epithelial cell adhesion complex for the structure
containing cytokeratins 5 and 14, hemidesmosomes including the proteins HD1,
BP 180 and BP 230, integrin α6β4, anchoring filaments or laminin-5 as well as
anchoring fibrils or type VII collagen (Fig. 3).
Fig. 3. Schematic figure of the hemidesmosome and epithelial cell adhesion
complex. Modified from Tuori, 1998.
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4.6 CYTOKERATINS
Microfilaments, microtubules, intermediate filaments, and the cell membrane
skeleton form the cellular cytoskeleton (Virtanen et al., 1989). Cytokeratins (Fig.
1), a multigene-derived family of more than 20 different polypeptides, are
intermediate filament proteins typical of epithelial cells. They are expressed in
different combinations in different epithelia (Moll, 1998). Cells of stratified
squamous epithelia contain cytokeratins in a typical form as a dense array of fibrils,
the tonofilaments. A different spectrum of cytokeratins is present in glandular
epithelia (Moll, 1998; Virtanen et al., 1989).
4.7 DEVELOPMENTAL ANATOMY
4.7.1 THYROID
The endodermal digestive canal in the foregut gives rise to organs such as the
thyroid gland (Arey, 1947). The thyroid is derived from the endodermal cells of the
pharyngeal floor (Hoyes and Kershaw, 1985; Norris, 1918). A medial ductlike
invagination and downward migration of endodermal cells of the primitive pharynx
takes place (Hoyes and Kershaw, 1985; Norris, 1918). Early in the seventh week
the thyroid gland becomes crescent-shaped and settles into a transverse position
with a lobe on each side of the trachea (Arey, 1947). At the ninth week, the cells
proliferate rapidly and form cords and trabeculas. These transform into follicular
structures, and the first small follicles are detectable at the age of 10 weeks
(Carcangiu, 1997). By week 14 there are well-developed follicles lined by
follicular epithelium. C-cells come from the neural crest (Carcangiu, 1997).
4.7.2 LARGE INTESTINE
The digestive system is derived from endodermal elements (Arey, 1947). In the 4
week embryo, the intestine is a simple tube. Later on in this developmental stage,
the coecum marks the boundary between the small and large intestine (Arey, 1947).
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The colon from the midgut to the distal third of the transverse colon section is
derived from the midgut, and the rest of the colon and rectum are from the hindgut
(Traber and Wu, 1995). At early stages of development, the colon consists of
stratified endoderm. At 9 weeks, protrusion of villiform structures into the lumen
takes place and at 10 to 11 week the first glands appear in the mucosa (Johnson,
1913; Traber and Wu, 1995). The villi continue to form, and at 16 weeks the lumen
is nearly filled with villi. Later, the villi disappear and are totally absent at birth
(Johnson, 1913; Traber and Wu, 1995).
Many epithelia, such as of the kidney and thyroid, mature fully during the late
foetal period. In some tissues, such as the intestine, epithelial cells continue to
proliferate and differentiate also after birth (Beaulieu, 1997). Hence, the intestine is
an interesting target for studying epithelial cell differentiation. In the colorectal
mucosa, the stem cells are located at the bottom of the crypt. The stem cells
proliferate, and start to migrate towards the gut lumen. The migration of the cells to
the mucosal surface takes 5 to 8 days in the human colorectal mucosa. During
migration, the cells differentiate and give rise to three different epithelial cell types:
colonocytes, goblet cells and enteroendocrine cells. Paneth cells are occasionally
present in the proximal colon (Traber and Wu, 1995).
4.8 BASEMENT MEMBRANE IN CARCINOMAS
The role of the BM in carcinoma biology is not well understood. Based mostly on
morphologic data, the loss of BM continuity has been associated with increasing
malignancy (Barsky et al., 1983; for a review, see Bosman, 1994). Various
proteolytic enzymes have an altered distribution and activity in malignant tissues
(Coussens and Werb, 1996), and it has been suggested that BM degradation is a
prerequisite for invasion (Barsky et al., 1983; Flug and Köpf-Maier, 1995). The
expression and activity of proteolytic enzymes in carcinomas is regulated by an
interaction between integrin and ECM, and by endogenous growth factors, as well
as by tissue inhibitors of metalloproteinases (TIMPs) (Coussens and Werb, 1996;
Heino, 1996). Liotta and Stetler-Stevenson (1991) have described the following
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three-step theory for the invasion of carcinoma cells through the BM: 1. The
tumour cells bind to the BM and ECM. 2. Proteolytic enzymes degrade the BM. 3.
The carcinoma cells are able to migrate and spread. However, continuous BM
structures have been found in some invasive carcinomas, and loss of BM continuity
has been found in some benign tumours (reviewed in Flug and Köpf-Maier, 1995).
Hence, it has been recently hypothesised that BM may not only be a barrier against
invasion, but rather an active and dynamic structure.
Various carcinoma cells are also active in synthesizing new BM molecules,
including laminins (Pyke et al., 1994; 1995;  Rabinovitz et al., 1994; Tani et al.,
1997; Wewer et al., 1994). As laminins have an active role in promoting migration
in normal epithelial cells it is conceivable that they have a similar role in
carcinomas. Miyazaki et al. (1993) have described an extracellular molecule called
ladsin, which promotes the migration of carcinoma cells. Later, ladsin has been
identified as laminin-5 which has been suggested to be a cell migration and
invasion promoting BM molecule (Berndt et al., 1999; Fukushima et al., 1998;
Giannelli et al., 1997; Tani et al., 1996a; 1997; Xia et al., 1996; Zhang and Kramer,
1996).
4.9 INTEGRINS IN CARCINOMAS
When considering the importance of integrins in cell adhesion, migration, and
signaling, it is worth mentioning that they are thought to play a crucial role in
carcinoma cell dissemination. They may regulate carcinoma cell proliferation,
apoptosis, invasion, angiogenesis, and extravasation (Clezardin, 1998; Keely et al.,
1998). Various integrin dimers have been suggested to act in the dissemination of
carcinomas. Integrin α3β1 and α6β4 complexes are the most potential integrins
acting in migration and invasion, along with laminins based on in vitro cell culture
experiments (Chao et al., 1996; Rabinovitz and Mercurio, 1997; Tani et al., 1997).
A wide variety of changes in the expression of integrins during malignant
transformation has been reported e.g., in the gastrointestinal tract (Streit et al.,
1996). However, there are no changes in the expression of integrins common for
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the malignant transformation in various organs and the literature is conflicting. e.g.
the expression of integrin α6β4 has been associated with both increasing (see e.g.
Rossen et al., 1994) and decreasing (Downer et al., 1993) malignancy.
4.10 RENAL NEOPLASIAS
Renal oncocytomas comprise about 2% of all renal neoplasias (Weiss et al., 1995).
This is a well-circumscribed benign tumour derived from the collecting duct
(Weiss et al., 1995). They consist of sheets of large cuboidal cells characterized by
eosinophilic granular cytoplasm and uniform round nuclei (Weiss et al., 1995).
Renal cancers account for 3.6% of all new cancers in Finland (Finnish Cancer
Registry, 1995). Renal cell carcinomas (RCCs) are usually well-circumscribed,
solid, soft, lobulated masses, but infiltration of the perirenal fat or renal vein are
possible. RCCs have a tendency to invade and spread to the inferior vena cava,
reaching even the right atrium. Typical sites of metastasis are lung, lymph nodes,
bone, and liver (Eble, 1996). The most important determinant of survival is the
anatomical extent of the tumour (the pathologic stage), whereas tumour
differentiation grade is less significant (Delahunt, 1998; Motzer et al., 1996).
Renal carcinomas are classified into five histological types: clear-cell,
chromophobe, papillary, granular, spindle cell, cyst-associated, and collecting-duct
carcinomas (Mostofi and Davis, 1998 WHO). Clear cell carcinomas are the most
common ones (75-85%). Further on in this thesis, the term “renal cell carcinoma”
(RCC) will be a synonym for clear-cell-type RCC. An RCC tumour is composed of
a mixture of cells with clear and granular cytoplasm and without papillary
formations (Weiss et al., 1995). The cellular origin of RCCs has been under debate.
Both proximal and distal tubular origins have been proposed, based on the
expression of various immunocytochemical markers specific for proximal
(Holthöfer et al., 1983; Oosterwijk., 1986; 1990) or distal (Fleming et al., 1985;
Korhonen et al., 1992) tubules.
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Papillary renal carcinomas (PRC) were earlier considered to be histologic variants
of the usual renal adenocarcinomas. However, PRC have distinct chromosomal
abnormalities different from those of other renal adenocarcinomas (Kovacs, 1989;
Palmedo et al., 1997), and hence should be considered a separate entity.
4.11 THYROID NEOPLASIAS
Thyroid carcinomas constitute about 1.8% of all new cancer cases in Finland
(Finnish Cancer Registry, 1995). The majority (95%) of thyroid tumours are
derived from thyroid epithelial cells (Carcangiu and DeLellis, 1996). Their
histological classification is based on their pattern of cell differentiation. Epithelial
thyroid tumours are classified as tumours of follicular cells or C-cells (Hedinger et
al., 1988 WHO). Benign follicular epithelial tumours include follicular adenomas,
atypical adenomas, and oncocytic (Hÿrtle cell) adenomas. 80% of the follicular cell
tumours are adenomas (Carcangiu and DeLellis, 1996). Malignant follicular
epithelial tumours include papillary, follicular, and anaplastic carcinomas.
(Hedinger et al., 1988 WHO). Papillary carcinoma is often unencapsulated, with
papillary and follicular structures (Schlumberger, 1998). It spreads through the
lymphatics to the regional lymph nodes (Schlumberger, 1998).
4.12 COLORECTAL NEOPLASIAS
Colorectal cancers account for 10.1% of all new cancer cases in Finland (Finnish
Cancer Registry, 1995). Colorectal neoplasias include adenomas, carcinomas, and
carcinoid and mesenchymal tumours. Epithelial tumours, adenomas and
carcinomas, are the most common ones. The incidence of adenomas increases with
advancing age (Owen and Kelly, 1996). Adenomas may develop at any site within
the large bowel; approximately one-third are located in the rectum or sigmoid
region (Owen and Kelly, 1996). Based on histology, adenomas are classified as
tubular, villous, or tubulovillous.
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Colorectal adenomas have a tendency to transform into carcinoma. Most colorectal
carcinomas arise in adenomas (Morson, 1974). The tendency to malignant
transformation in an adenoma increases with increasing tumour size, presence of
villous components, and dysplasia (Owen and Kelly, 1996). Histologically, most
carcinomas are well or moderately differentiated and composed of irregularly
shaped glands and branching cords of tumour cells (Owen and Kelly, 1996).
The most important prognostic factor in colorectal carcinomas is the stage.
Colorectal carcinomas are often classified according to Dukes into stages A to D,
according to their dissemination (Fisher et al., 1989). Lymph nodes in the pericolic
fat, mesentery, retroperitoneum, and porta hepatis are often affected (Owen and
Kelly, 1996).
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5. AIMS OF THE STUDY
The purpose of the study was to investigate changes in the expression of laminin
chains during development and malignant transformation of epithelial elements. As
target tissues, I choose kidney, thyroid, colon, and rectum. The specific goals were:
1. To study changes in the expression of laminins and integrins during maturation
of thyroid follicular epithelium.
2. To study the expression of laminins in foetal and mature colorectal mucosa and
to explore whether the laminin expression pattern correlates with the
localisation of undifferentiated stem cells and the differentiated epithelia.
3. To study the expression of laminins in human renal carcinomas, and in renal
carcinoma cells in vitro and in vivo xenografts.
4. To explore the expression of laminin-5 and hemidesmosomally associated
proteins during malignant transformation of thyroid follicular epithelium and to
resolve whether their expression correlates with cell proliferation and squamous
differentiation.
5. To study the expression of laminin-5 and its integrin receptors in colorectal
neoplasias and to resolve which integrin complex binds laminin-5 in colon
carcinoma cells.
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6. MATERIALS AND METHODS
6.1 TISSUE SAMPLES
Samples of RCCs (n=34), PRCs (n=2), metastases of RCC (n=3), and oncocytomas
(n=3) were obtained from nephrectomies performed at the Jorvi Hospital (Espoo)
and at the Oulu University Central Hospital (Oulu). Samples of normal kidney
(n=4) were obtained from areas not involved with tumour. RCCs and their
metastases were graded by the criteria of WHO based on the degree of anaplasia
and the nuclear size (Mostofi and Davis, 1998) as grades G1 (n=13), G2 (n=15),
and G3 (n=6).
Thyroid specimens were obtained from the Department of Oncology at the
Helsinki University Central Hospital (Helsinki) and at the Jorvi Hospital (Espoo).
The tumour samples were six follicular, 16 papillary, six anaplastic and six
medullary carcinomas as well as five follicular and six atypical adenomas. The 10
specimens of normal adult thyroid glands were uninvolved parts of thyroid glands
operated on for adenoma or carcinoma. These operations were all performed at the
Jorvi Hospital.
Colorectal tumour specimens were obtained from operations at the 2nd Department
of Surgery at the Helsinki University Central Hospital. The tumour samples were:
9 adenomas (2 tubular, 6 tubulovillous, 1 villous), 37 carcinomas (7 Dukes stage A,
14 stage B, 11 stage C, and 5 stage D). The grade of the carcinomas was measured
according to Sobin and Wittekind (1997) (2 G1, 18 G2, 16 G3, 1 G4). Specimens
of normal adult colon (n=20) and rectum (n=11) were obtained from operations at
the 2nd Department of Surgery at the Helsinki University Central Hospital.
Human foetal thyroid (16-19 weeks, n=4) and colon (16 weeks, n=2) samples were
obtained from abortions performed for severe maternal complications, or from
spontaneous abortions at the Department of Gynaecology of Helsinki University
Central Hospital (Helsinki).
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Tissues were frozen in liquid nitrogen. Frozen sections were cut at 6µm, and fixed
in acetone precooled to -20oC. Tissue sections were stained with hematoxylin-eosin
to evaluate the histology.
6.2 CELL CULTURE
Cells were cultured in RPMI 1640 medium (Sigma) supplemented with 10% foetal
calf serum (Sigma). RCC cell lines came from the American Type Culture
Collection (ATCC, Manassas, VA, USA). The A498 (Giard et al., 1973) and
CAKI-2 (Fogh et al., 1977) are from primary renal carcinoma, CAKI-1 (Fogh et
al., 1977) from a cutaneous metastasis of a renal carcinoma, and ACHN (Giard et
al., 1973) from malignant pleural effusion of a patient with metastatic renal
adenocarcinoma. Cell lines from colon adenocarcinomas DLD-1 (Chen et al.,
1983) and HT29 (Noguchi et al., 1979) were also purchased from the ATCC. The
Clone-A (Dexter et al., 1979) colon adenocarcinoma cell line was kindly provided
by Professor Arthur M. Mercurio (Boston, MA, USA).
6.3 XENOGRAFTS
For generation of the xenografts, 5 x 106 RCC cells were injected into the
subcutaneous tissue of nude mice kept at the Cancer Research Laboratory of the
Farmos Research Corporation (Orion, Turku, Finland). Mice were sacrificed when
a 10-15 mm tumour could be palpated.
6.4 IMMUNOHISTOCHEMISTRY
The antibodies used are listed in Table II.
Immunostainings for light microscopy were done with the alkaline phosphatase-
anti-alkaline phosphatase (APAAP) technique (DAKO, Glostrup, Denmark) or
with the peroxidase technique, Vectastain ABC Mouse IgG KitR (VECTOR
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Laboratories, Burlingame, CA, USA). Colour reactions were developed with
naphtol AS-BI phosphate (Sigma) or with diaminobenzidine (DAB) combined with
ammonium sulphate.
For indirect immunofluorescence, the sections were exposed to MAb, washed in
PBS, and then exposed to FITC-coupled sheep anti-mouse IgG serum or sheep
anti-rat IgG serum (Jackson Immunoresearch, West Grove, PA, USA). For the
double indirect immunofluorescence technique, the sections were additionally
exposed to polyclonal rabbit antiserum, followed by TRITC-coupled sheep anti-
rabbit anti-serum (Jackson).
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Table II. Antibodies, their specificity and references.
Antibody Specifity Reference or source
TS2/7 α1 Integrin Hemler et al., 1984
10G11 α2 integrin Giltay et al., 1989
P1H5 α2 integrin
(functional experiments)
Wayner et al., 1988
J143 α3 Integrin Hemler et al., 1984; Fradet et al., 1984
P1B5 α3 Integrin
(functional experiments)
Wayner et al., 1988
B5-G10 α4 Integrin Hemler et al., 1987
B1E5 α5 Integrin Werb et al., 1989.
GoH3 α6 Integrin Sonnenberg et al., 1987
LM142.69 αV Integrin Cheresh and Spiro., 1987
102DF5 β1 Integrin Ylänne and Virtanen, 1989
13 β1 Integrin
(functional experiments)
Yamada et al., 1990
87DB10 β3 Integrin Ylänne et al., 1988
AA3 β4 Integrin Tamura et al., 1990
1A9 β5 Integrin Pasqualini et al., 1993
E7P6 αVβ6 Integrin Weinacker et al., 1994
1D1 BP180 Owaribe et al., 1991
IE5 BP230 Owaribe et al., 1991
HD-121 HD1 Hieda et al., 1992
2G9 α2 laminin chain Leivo and Engvall, 1988
BM-2 α3 laminin chain Rousselle et al., 1991
4C7 α5 laminin chain Engvall et al., 1986; Tiger et al., 1997
3E5 β1 laminin chain Engvalll et al., 1986
114DG10 (PLB1) β1 laminin chain Virtanen et al., 1997
C4 β2 laminin chain Hunter et al., 1989
BM-140 β3 laminin chain Marinkovich et al., 1992
2E8 γ1 laminin chain Engvall et al., 1986
GB3 γ2 laminin chain Matsui et al., 1995
II,32 VII collagen Sakai et al., 1986
M3F7 Collagen IV α1, α2 Foellmer et al., 1983
100EB2 Tenascin-C isoforms Howeedy et al., 1990; Balza et al., 1993
BC-4 Tenascin-C isoforms Siri et al., 1991
BC-2 Tenascin-C HMW isoform Balza et al., 1993
52BF12 Fibronectin isoforms Vartio et al., 1987
VN2 Vitronectin Ljungberg et al., 1996
EC-1 PECAM-1 Tani et al., 1996b
KA1 Cytokeratin-5 Nagle et al., 1986
Ki-67 Proliferative cells Brown and Gatter, 1990
Polyclon Laminin-5 complex Rousselle et al., 1991
1141 Polyclon EHS Laminin Liesi et al., 1983
Polyclon Laminin α1 chain Tiger et al., 1997
Polyclon Laminin γ2 chain
Immunoblotting experiments
Sugiyama et al., 1995
Polyclon  collagen IV α3, α4 and α
5 chains
Miner and Sanes, 1994
Polyclon collagen IV α6 chain Peissel et al., 1995
Polyclon band 3 protein Wagner et al., 1987
Polyclon Myosin Sigma. St Louis, MO, USA
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6.5 WESTERN BLOTTING
For this purpose, 20 Wm sections were cut from frozen tissue specimens. Then the
specimens were exposed to 0.5M deoxycholate (Sigma) in 50 mM Tris to enrich
the ECM material. Cultured cells were first washed in PBS, pH (7.4), and
subsequently harvested and boiled in the electrophoretic sample buffer. Samples
were run in sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-
PAGE) according to Laemmli’s procedure using 6.5% slab gels and reducing
conditions. Subsequently, proteins were transferred onto PVDF membranes
(Millipore) or onto nitrocellulose (BIO-RAD). Visualization was done by use of a
chemiluminescence kit (Boehringer-Mannheim, Mannheim, Germany) or by
immunostaining with the APAAP technique.
6.6 IMMUNOPRECIPITATION AND SDS-PAGE
Cultured cells were labeled in a serum- and methionine-free minimum essential
medium (MEM; Sigma) containing 20 µCi/ml (35S) methionine (1000 Ci/mmol;
Amersham, Aylesbury, UK) overnight. Then, the culture medium was removed,
made up to 0.5% for Triton X-100 and cleared by centrifugation. Supernatants
were pre-cleared by stirring with normal rabbit serum and protein G SepharoseR
beads (Pharmacia, Uppsala, Sweden). After centrifugation, the supernatant was
removed and applied onto Gammabind® Sepharose® beads pre-incubated with
MAb or anti-serum and rotated overnight at 4°C. The beads were washed 4 times
in PBS containing 0.5% Triton-X-100 and 1mM phenylmethyl sulfonylfluoride,
and the proteins were then solubilized in electrophoresis sample buffer. Samples
were run in SDS-PAGE on 5% slab gels under reducing conditions, and the gels
were subjected to fluorography.
6.7 CELL ADHESION ASSAYS
Cell adhesion was studied in 96-well plates by a method based on the detection of
intracellular acidic phosphatase (Prater et al., 1991). For the adhesion assays,
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laminin-5 was purified by immunoaffinity chromatography from culture medium
of human foreskin keratinocytes as described earlier (Rousselle et al., 1997). Then
the wells were coated with laminin-5 (2 µg/ml) at room temperature for 1 hour and
washed twice with phosphate-buffered saline (PBS). Subsequently, the wells were
postcoated with 3% bovine serum albumin (BSA) in PBS for 60 min and washed
three times with PBS. Trypsinized cells were suspended in RPMI 1640 medium
without serum,  then seeded in wells and incubated for 2 hours, and then washed
three times with PBS; 100-µl of the substrate solution (6 mg/ml Sigma 104
phosphatase substrate in 50 mM acetate buffer, pH 5.0, mixed with 1% of Triton
X-100) was added to each well, and plates were incubated at 37oC for 1 hour. The
reaction was stopped by addition of 50 µl of 1M NaOH. Absorbances were
measured at 405 nm. Each experiment was done in triplicate. Standard deviations
were used to evaluate variation in absorbance values. Statistical significance of
differences in the absorbance values was evaluated with a SPSS statistic program
and Scheffe’s test.
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7. RESULTS
7.1 NORMAL, DEVELOPING, AND MATURE TISSUES
7.1.1 LAMININS AND INTEGRINS IN THYROID FOLLICULAR
EPITHELIUM
Laminin α5, β1, β2, and γ1 chains were found in the foetal and mature thyroid
follicular epithelial BMs. Expression of the laminin β2 chain was much weaker in
mature thyroid follicular epithelial BM than in foetal thyroid.
Among the wide spectrum of integrin subunits (α1-α6, αv, β1, β3-β5, αvβ6) tested,
integrins α3, αv, and  β1 were found in foetal (16-19 week) thyroid follicular
epithelium in a diffuse manner. In adult thyroid follicular epithelium, integrin α3,
αv, and β1 subunits were seen basally in a polarized manner. Additionally, integrin
β3 was found in mature thyroid follicular epithelium, but distributed in a more
basolaterally-confined manner
7.1.2 LAMININS IN COLORECTAL MUCOSA
Immunoreactivity to laminin α5, β1, and γ1 chains was detectable in epithelial
BMs of foetal (16 week) colon mucosa. Immunoreactivity to laminin α3 and β3
chains was detectable in the tip of the villi, but only weakly in lower parts of the
villi in foetal colon mucosa. Immunoreactivity to laminin α2 and β2 chains and to
type VII collagen was lacking in foetal colon mucosa.
Immunoreactivity to laminin α5, β1, and γ1 chains was also seen in the epithelial
BM of the adult colorectal mucosa. Immunoreactivity to laminin α3 and β3 chains
was strong in the BMs of surface epithelium and in the upper parts of the crypts in
adult colorectal mucosa. Crypt bottoms  had a weaker immunoreactivity to laminin
α3 and β3 chains. Immunoreactivity to the laminin α2 chain was seen at the
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bottom of the crypts, located around the pericryptal fibroblasts in adult colorectal
mucosa. Immunoreactivity to the laminin β2 chain was variably detected in
epithelial BMs of adult colorectal mucosa. Immunoreactivity to type VII collagen
was seen in epithelial BMs of the adult colorectal mucosa. The reactivity was
stronger in the BMs of the surface epithelium than in the lower parts of the crypts.
There was no immunoreactivity to the laminin α1 chain in the adult colorectal
mucosa (unpublished results).
7.2 NEOPLASIAS
7.2.1 LAMININS IN RENAL CELL CARCINOMAS
Immunoreactivity to laminin α5, β1, and γ1 chains was widely seen in BMs of
RCCs and PRCs. Immunoreactivity to the laminin α2 chain was lacking in renal
tumours. Immunoreactivity to the laminin β2 chain was seen in BMs of RCCs, but
was lacking in PRCs. Immunoreactivity to laminin α3 and β3 chains and to
laminin-5 complex was lacking in RCCs, but was found in PRCs.
In well-differentiated carcinomas, BMs of carcinoma cell islets were discernible
from BMs of blood vessels, but in poorly differentiated ones these were not always
discernible, at the resolution of fluorescence microscopy.
Oncocytomas presented immunoreactivity to laminin α5, β1, γ1, and β2 chains.
Reactivity to laminin α3 and β3 chains and to the laminin-5 complex was detected
in two out of three oncocytomas. Reactivity to the laminin α2 chain was lacking in
oncocytomas.
7.2.2 PRODUCTION OF LAMININS BY RENAL CELL CARCINOMA
CELLS IN VITRO AND IN VIVO
In the immunoprecipitation experiments, laminin α5, β1, and γ1 chains were
produced by ACHN, A498, CACI-1, and CACI-2 RCC cells. The laminin β2 chain
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was produced by ACHN and A498 cells. Laminin α3 and β3 chains were not
produced by cultured RCC cells.
To obtain information on the role of intrinsic and extrinsic factors in regulation of
laminin expression in RCC cells, we studied the expression of laminins in in vivo
xenografts by using species specific antibodies. Immunoreactivity with human-
specific MAbs for laminin α5, β1, and γ1 was seen in all xenograft tumours located
in BMs. Immonoreactivity to laminin α3 and β3 chains was found in BMs of
ACHN, CAKI-1, and CAKI-2 xenografts. Laminin β2 chain was detected in BMs
of the A498 xenograft. Immunoreactivity to the α2 chain was lacking in
xenografted tumours.
7.2.3 LAMININS, INTEGRINS, AND HEMIDESMOSOMAL ANTIGENS
IN THYROID NEOPLASIAS
Immunoreactivity to laminin α3, β3, and γ2 chains, VII collagen, and integrins α6
and β4, as well as to the hemidesmosomal antigen HD1, was detectable in most of
the thyroid tumours. The results are summarized in Table III. Typically, they were
detected at the boundary between tumour parenchymal cells and a stromal
compartment. They were most widely expressed in atypical adenomas and in
papillary as well as anaplastic carcinomas. The bullous pemphigoid antigens 180
and 230 (BP180 and BP230) were expressed in some papillary carcinomas and
atypical adenomas as well as in anaplastic carcinomas. Immunoreactivity to all
these antigens was closely coaligned with cells immunoreactive to cytokeratin-5
and to a high expression of the proliferation marker, Ki-67.
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Table III. Expression of the components of epithelial cell adhesion complex
antigens in thyroid neoplasms.
7.2.4 LAMININS AND THEIR INTEGRIN RECEPTORS IN COLORECTAL
NEOPLASIAS
In the BMs of adenomas, there was immunoreactivity to laminin α3, β3, and γ2
chains as well as α5, β1, and γ1 chains and to type VII collagen. There was no
immunoreactivity to the laminin α1 chain in colorectal adenomas.
In colorectal carcinomas, immunoreactivities to laminin α3, β3, and γ2 chains were
widely seen in the BMs, often accumulated at the invading edge. Immunoreactivity
to laminin α5, β1, and γ1 chains was seen in the BMs of carcinomas, but was often
lacking in the invasive area. There was no immunoreactivity to laminin α1 chain or
type VII collagen in colorectal carcinomas.
In western blotting experiments on two carcinoma samples using a polyclonal
antiserum to the laminin γ2 chain, 155 and 105 kD polypeptides were detectable,
corresponding to the precursor and the mature laminin γ2 chain (Matsui et al.,
1995; Rousselle et al., 1991).
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There was an abundant immunoreactivity to integrin α6 and β4 subunits in
adenomas as well as in carcinomas. A variable immunoreactivity to integrin α2 and
β1 subunits was seen in all tumour samples. Immunoreactivity to the integrin α3
subunit was seen in all colorectal adenomas and in 33 out of 37 carcinomas. Co-
localisation of immunoreactivities to integrins α3 and β1 with reactivity to laminin-
5 was often detectable.
7.2.5 PRODUCTION OF LAMININ-5 BY CULTURED COLON
CARCINOMA CELLS
In immunoprecipitations by polyclonal anti laminin-5 antiserum of S35 –
methionine-labeled colon carcinoma cell culture media, a very weak 200-190 kD
polypeptide, corresponding to the laminin α3 chain, was detectable in culture
media of Clone A cells. A 160 kD polypeptide, corresponding to the processed
laminin α3 chain, was detected in Clone A and HT29 cultures. Polypeptides of 155
and 140 kD, corresponding to laminin γ2 and β3 chains, were detected in all
culture media. A 105 kD polypeptide, corresponding to the processed laminin γ2
chain, was detectable in clone A and HT29 cell cultures.
7.2.6 ADHESION OF COLON CARCINOMA CELLS TO LAMININ-5
Function-blocking MAbs to integrin α3 and β1 subunits inhibited the adhesion of
DLD-1, HT29, and Clone-A cell lines to purified laminin-5. The function-blocking
MAbs to integrin α2 or α6 subunits had no effect in the adhesion experiments (Fig.
4).
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Fig. 4. Adhesion of colorectal carcinoma cells to laminin-5 and inhibition of
this adhesion by MAbs for integrins. The mean of absorbances of three
separate wells describes the number of adhered cells. Adhesion could be
inhibited by MAbs J143 against integrin α3, and 13 against integrin β1, but
not by P1H5 against integrin α2, or GoH3 against integrin α6. Narrow line at
the top of the columns shows magnitude of standard deviation.
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8. DISCUSSION
8.1 CHANGES IN  THE EXPRESSION OF LAMININS AND THEIR
INTEGRIN RECEPTORS DURING ORGAN MATURATION
Laminin β1 and γ1 chains can be detected in the cells after the 2- to 4-cell stage of
the developing embryo (Dziadek and Timpl, 1985), and they are essential for
development starting with the early phases of endodermal differentiation (Smyth et
al., 1999). Later during organogenesis, the expression of laminin is regulated,
leading to tissue and developmental stage-specific localisation of isoforms, an
argument for their importance in the development of various organs (Aumailley
and Smyth, 1998). Integrins are also essential for development, and their
expression and distribution pattern is developmentally regulated (Beaulieu, 1997;
Beauvais-Jouneau and Thiery, 1997; Ekblom, 1996). This study provides some
examples of transitions in the expression of laminins and their integrin receptors
during organ maturation. The expression of laminins and integrins in adult tissues
is compared to that in 16- to  19-week foetal tissues. Organ structures have already
formed in the 16-week embryo, but epithelial maturation still goes on.
8.1.1 THYROID
Laminin trimers present in thyroid follicular epithelial BMs appeared to be
laminin-10 (α5β1γ1) and laminin-11 (α5β2γ1). The expression of the laminin β2
chain and laminin-11 decreases during maturation. Polarization of integrins α3, αv,
and β1 and the emergence of integrin β3 takes place during maturation of the
thyroid follicular epithelium. The results suggest that integrin combinations α3β1,
αvβ1, and αvβ3 may interact with laminins -10 and -11 in thyroid follicular
epithelium. The role of integrins and laminins may be important in follicular
epithelial maturation into functionally active cells, whereas cadherin-mediated cell-
cell contacts are important in earlier follicle formation (Yap et al., 1995). The
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expression of integrins during differentiation is regulated by cadherins and cell-to-
cell contacts (Vitale et al., 1995; Hodivala and Watt, 1994).
8.1.2 COLON AND RECTUM
In contrast to thyroid gland, in the colorectal mucosa laminin β2 chain emerges in
the epithelial BM during development. Developmental variation in the expression
of the laminin β2 chain has recently been found also in the rat conjunctiva, human
bronchi, and in human and rat kidney glomeruli (Miner et al., 1997; Tuori et al.,
1998; Virtanen et al., 1995b; 1996a). Hence, it is probable that the laminin trimer
containing the β2 chain (laminin-11, α5β2γ1) is important in the maturation of
various epithelia.
Laminin γ2 chain expression also seems to be developmentally regulated in the gut.
Based on mouse/chicken hybrid intestine experiments, the laminin γ2 chain has
been suggested to be deposited by undifferentiated epithelial cells at the early stage
of development and by mesenchymal cells at later stages, giving rise to the adult
pattern (Orian-Rousseau et al., 1996). However, they found the laminin α3 chain
only in adult intestine. A laminin trimer with the γ2 chain but without the α3 chain
is thus far unknown (Miner et al., 1997; Timpl and Brown., 1996). My results
showed an expression of laminin α3 and β3 chains at least at the 16-week
developmental stage of foetal human colon mucosa.
Type VII collagen emerges in the BM during maturation of colorectal epithelium.
In the adult gut, type VII collagen and laminin-5 are located in the most
differentiated cells on the mucosal surface. Laminin-5 may be active in promoting
the differentiation of the dividing cells of the gastrointestinal tract towards the
surface-type cell (Leivo et al., 1996; Virtanen et al., 1995a). Switches in laminin
chain expression may be important also in the migration of gut epithelial cells
towards the surface (Ekblom et al., 1996).
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Moreover, the laminin α2 chain emerges in the colorectal mucosa during
maturation, but it appears to surround the pericryptal myofibroblasts rather than
being a component of the epithelial BM. In line with this suggestion, mutant mice
lacking the laminin α2 chain suffer severe muscular dystrophy, but the intestinal
epithelial morphogenesis is not disturbed, and the absence of the laminin α2 chain
does not prevent the differentiation of epithelial stem cells (Simon-Assmann et al.,
1994).
8.2 EPITHELIAL ADHESION COMPLEX ANTIGENS IN SIMPLE
EPITHELIA
The expression of type VII collagen and laminin-5 has been associated with typical
hemidesmosomal epithelial cell adhesion complexes containing integrin α6β4,
anchoring filaments, and anchoring fibrils (Gerecke et al., 1994). Their expression
has been thought to be restricted to BMs of stratified and squamous epithelium
(Gerecke et al., 1994; Leigh et al., 1987; Rousselle et al., 1991; Utani et al., 1995;
Wetzels et al., 1991). However, hemidesmosomes may be present also in simple
epithelium, such as in thymic capsular epithelium (Virtanen et al., 1996b; von
Gaudecker, 1991). On the other hand, one component of the epithelial cell
adhesion complex, integrin α6β4, may be expressed in cells lacking
hemidesmosomes (Jones et al., 1998). Type VII collagen and laminin-5 are
expressed in simple cuboidal (loop of Henle) and columnar epithelial (colorectal
mucosal epithelium) BMs. Intestinal epithelium expresses HD1 protein (Orian-
Rousseau et al., 1996). Hence, laminin-5 and type VII collagen and HD1 may be
expressed in tissues lacking classical hemidesmosomes (Leivo et al., 1996). In
conclusion, various components of the epithelial cell adhesion complex are
variably expressed in different simple epithelia, e.g. thyroid follicular epithelium
lacks all these components. In the kidney, most tubules lack all components, but
the tubules of the loop of Henle contain at least laminin-5 as well as integrin α6β4.
Intestinal epithelium contains integrin α6β4, HD1, type VII collagen, and laminin-
5.
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8.3 EXPRESSION OF LAMININS –1 AND -10 IN EPITHELIAL TISSUES
The literature concerning the distribution of laminin-1 and its α1 chain in tissues of
various species is controversial. Numerous studies including three original
publications, which is part of the present thesis have described the widespread
expression of laminin-1 and the laminin α1 chain in the BMs of human epithelial
tissues. These studies were mostly performed with the MAb 4C7 (Engvall et al.,
1986) or by polyclonal anti laminin antiserum 1141 (Liesi et al., 1983). Other
studies have suggested a more restricted expression of the laminin α1 chain. In
newborns an expression of the laminin α1 chain mRNA has been found only in
kidney, testis, and neuroretina (Nissinen et al., 1991; Vuolteenaho et al., 1994). A
transient and locally restricted tissue distribution for laminin α1 chain mRNA has
been described in mouse tissues (Ekblom et al., 1990; Klein et al., 1990).
Immunohistochemical studies with murine tissues have shown that the laminin α1
chain polypeptide distribution in kidneys is restricted to proximal tubular BMs
(Durbeej et al., 1996; Kadoya et al., 1995; Klein et al., 1990; Miner et al., 1997;
Sorokin et al., 1997). Recently, a selective immunoreactivity in proximal tubules of
the human kidney has also been shown by a new antiserum against the laminin α1
chain (Tiger et al., 1997). It is now clear that the controversial results can be
explained based on the specificity of MAb 4C7, which detects the laminin α5 chain
but not the laminin α1 chain (Church and Aplin, 1998; Kikkawa et al., 1998; Tiger
et al., 1997). Antiserum 1141 can react also with other laminins in addition to
laminin-1, due to its reactivity with epitopes in the laminin β1 and γ1 chains
(Tuori, 1998). In this study, the results using the MAb 4C7 will be considered to
indicate the expression of the laminin α5 chain.
The laminin α1 chain and laminin-1 appear to have a restricted tissue distribution
in adult mammalian epithelia. However, they are transiently present in developing
organs and may play an important role in organogenesis (Miner et al., 1997). The
laminin α5 chain and laminin-10 appear to be rather ubiquitous BM components
(Miner et al., 1995; 1997). The laminin α5 chain appears to be an evolutionally
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conserved laminin chain, as it resembles the laminin α chain in Drosophila (Miner
et al., 1995).
8.4 LAMININS AND INTEGRINS IN NEOPLASIAS
8.4.1 RENAL NEOPLASIAS
In laminin immunostainings, the BMs of RCCs and endothelial cells were seen as
separate structures at the resolution of the fluorescence microscopy in well-
differentiated carcinomas, but not in poorly differentiated carcinomas, suggesting a
pathological merging of the BM structures in the latter. RCCs have a tendency to
spread via blood vessels (Motzer et al., 1996). Hence, the BM merging may be a
prerequisite for RCC cells to invade blood vessels. Endothelial BMs in RCCs differ
from normal human intertubular capillary BMs by their prominent contents of
laminin α5 and β2 chains.
Both RCCs and PRCs were widely immunoreactive to chains which are part of
laminin-10. However, their BMs differ in molecular composition. In PRCs, but not
in RCCs, the laminin α3 and β3 chains of laminin-5 are present. The Laminin β2
chain is present in BMs of RCCs, but not in PRCs. Among hemidesmosomally
associated proteins, PRCs express also integrin α6β4 and HD1 antigen (Lohi et al.,
1998), which are lacking in RCCs. The distribution of type IV collagen chains in
PRCs is also different from that of RCCs (Lohi et al., 1997). PRCs have
chromosomal abnormalities distinctive from RCCs (Kovacs, 1989; Palmedo et al.,
1997). Hence, PRC is not a histological variant of RCCs, but rather as a separate
entity (Weiss et al., 1995).
Renal oncocytomas are thought to be distinct from other renal tumours. They are
suggested to be derived from intercalated cells in the collecting duct rather than
from cells in the kidney tubules (Störkel et al., 1998). The specific BM
composition in oncocytomas supports their being a separate entity.
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Cell culture and xenograft experiments with RCC cells show that they produce
laminin-10 independent of environmental regulation. The host factors in nude mice
upregulated the production of laminin-5 and partly downregulated production of
the laminin β2 chain. The expression of the laminin β2 chain and chains of
laminin-5 appeared to be reciprocally expressed in RCC cells.
8.4.2 THYROID NEOPLASIAS
In thyroid carcinomas, neoexpression of laminin-5, type VII collagen, integrins α6
and β4, HD1, and occasionally also BP 180 and BP 230 took place. Their
expression was located at the epithelial-stromal interface. They were expressed in
cells which also expressed cytokeratin-5, a marker of squamous differentiation. In
line with these results, Miettinen et al., (1997) have recently described the
expression of stratified epithelial keratins in papillary thyroid carcinomas, and they
speculated that the stroma-epithelial interaction may induce complex epithelial
differentiation in these tumours.
The expression of epithelial cell adhesion complex proteins is associated also with
a high expression of Ki-67, a marker of proliferative cells, suggesting their activity
in cell proliferation. The cytoplasmic domain of integrin β4 is associated with
signal transduction molecules and is linked to the p21 pathway, which regulates the
cell cycle, and integrin β4 is tyrosine-phosphorylated when the α6β4 heterotrimer is
interacting with laminin-5 (Jones et al., 1998; Mainiero et al., 1995). Moreover, the
interaction between integrin α6β4 and laminin-5 has been suggested to activate T-
cell proliferation via tyrosine phosphorylation (Vivinus-Nebot et al., 1999). Hence,
the interaction of integrin α6β4 with laminin-5 may play a role in the activation of
cell proliferation in thyroid carcinoma.
One interesting question is whether there are also hemidesmosomal structures in
papillary thyroid carcinomas. In anaplastic carcinomas, the expression of
hemidesmosome-associated antigens and squamous differentiation markers may be
due to a randomly accelerated function of various transcription factors. In the
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anaplastic thyroid carcinomas the expression of integrin α2  is also upregulated
(Dahlman et al., 1998).
The expression of adhesion complex proteins is associated with papillary
morphology both in renal and in thyroid carcinomas. This observation allows one
to hypothesise whether the expression of adhesion complex proteins is a general
propensity of neoplasias with papillary morphology. Laminin-5 plays a role in
branching morphogenesis in normal developing tissue (Stahl et al., 1997). It is
possible that it acts also in the branching of papillae in papillary tumours.
Accelerated deposition of BM material has recently been noticed in ovarian
carcinomas with a papillary growth pattern (Mikami et al., 1999).
8.4.3 COLORECTAL NEOPLASIAS
Laminin-1 has been thought to be present in a wide variety of carcinomas. In
colorectal carcinomas, several studies in which polyclonal anti-laminin sera have
been used have suggested the presence of laminin-1 (Daneker et al., 1987; Foster et
al., 1984; 1986; Hida et al., 1994; Khan et al., 1998; Kiyoshima et al., 1998).
Additional studies by Hewitt et al. (1997) and Ljubimov et al. (1992) have
suggested the presence of components of laminin-1 in colorectal carcinomas based
on work with monoclonal antibodies. Cultured colorectal carcinoma cells have also
been described to produce laminin-1 (Rgmy et al., 1992). Various experimental in
vitro colon carcinoma studies, using mouse-derived laminin-1, have been
performed to answer the question as to the role of laminin-1 in carcinoma cell
biology. Results of this study using a new antiserum against the laminin α1 chain
(Tiger et al., 1997) show the total lack of laminin-1 in colorectal neoplasms.
Hence, laminin-1 cannot play a major role in the pathology of colorectal adenomas
and carcinomas. Different results can be explained by the specifity of antibodies
(see chapter 8.3).
Type VII collagen is widely expressed in the BMs of colorectal adenomas which
reflect the properties of the colorectal mucosal surface epithelium. This situation is
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analogous to premalignant changes in the gastric mucosa (Tani et al., 1996a). The
loss of type VII collagen expression during the acquisition of a malignant
phenotype appears to be a common propensity of at least colorectal, gastric, and
laryngeal carcinomas (Hagedorn et al., 1998; Nerlich et al., 1998; Tani et al.,
1996a).
In contrast to type VII collagen, laminin-5 is not lost during malignant
transformation, because all its constituent chains are present in colorectal
adenomas and carcinomas. Earlier in situ hybridization studies have suggested that
mRNA for the laminin γ2 chain of laminin-5 is expressed in invasive colon
carcinomas (Pyke et al., 1994; 1995), and our results suggest that laminin-5 is
produced also at the protein level. Because the MAb GB3 has the propensity to
react with the laminin γ2 chain only when it is complexed in trimeric laminin-5
(Chan et al., 1995), laminin-5 chains in colorectal carcinomas must mostly form a
trimeric laminin-5 macromolecule.
The well-known activity of laminin-5 as a cell-migration, and invasion-promoting
factor (Berndt et al., 1999; Fukushima et al., 1998; Giannelli et al., 1997; Miyazaki
et al., 1993; Tani et al., 1997; Xia et al., 1996; Zhang and Kramer, 1996) suggests
that laminin-5 plays a role in colorectal carcinoma invasion and dissemination. One
possible mechanism of laminin-5 in the promotion of cell migration is an activation
of the laminin γ2 chain by cleavage (Giannelli et al., 1997; 1999). It appears that
this mechanism does not exist in colorectal carcinomas, as the immunoblotting
experiments in the present study showed no small cleaved polypeptides but only
the normal 155 000 and 105 000 kD polypeptides from the laminin γ2 chain
(Matsui et al., 1995),. Neither does the laminin β3γ2 dimer chain appear to play a
role in invasion by colorectal carcinomas as suggested by Sordat et al. (1998),
because the present finding showed that laminin-5 was present in a trimeric form
outside colorectal carcinoma cells in vivo and in vitro.
Among the laminin-binding integrins, the α2β1, α3β1, and α6β4 complexes are the
most potential factors acting with laminin-5 in gastrointestinal carcinoma-cell
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invasion (Orian-Rousseau et al., 1998; Sordat et al., 1998; Tani et al., 1996a;
1997). All these integrins exist in most colorectal carcinomas, although the
expression of integrins α2β1 and α3β1 is reduced in poorly differentiated
carcinomas (Beaulieu, 1997; Koukoulis et al., 1993; Lindmark et al., 1993; Nigam
et al., 1993; Sordat et al., 1998; Stallmach et al., 1992). Immunohistochemical
results reveal that polarization of integrin α3 and β1 subunits takes place during
malignant transformation of colorectal neoplasms. Adhesion experiments with
function blocking antibodies indicate that integrin α3 and β1 subunits, but not α2 or
α6 subunits, act in binding of colon carcinoma cells to laminin-5. These results
suggest an interplay of integrin α3β1 with laminin-5 in colorectal carcinomas.
Integrin complex α3β1 has been suggested to be involved in melanoma, glioma, and
carcinoma cell invasion and migration (Melchiori et al., 1995; Tani et al., 1997;
Tysnes et al., 1996). There is experimental evidence for the role of integrin β1 in
the malignancy of colorectal carcinoma cells, because anti-β1 integrin antibodies
inhibit the invasion of colorectal carcinoma cells in vitro (Schlaeppi et al., 1997).
Furthermore, alterations in the cell-membrane distribution of integrin β1 increase
the tumourigenicity of colon carcinoma cells in nude mice (Kim et al., 1994-95).
Binding of the human colon carcinoma cell line to laminin-5 via the integrin α3β1
complex activates cell motility by using tyrosine phosphorylation of the focal
adhesion kinase as a downstream signaling molecule (Xia et al., 1996). Hence, the
integrin α3β1 complex may use laminin-5 as a ligand, and this complex may play a
role in the invasion of colorectal carcinomas.
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9. SUMMARY
In this thesis I have studied the distribution of laminins and integrins in the
developing and adult thyroid and colorectum as well as in kidney, thyroid, and
colorectal carcinomas. The production of laminins by carcinoma cells in in vitro
conditions was studied, using immunoprecipitation. Function-blocking antibodies
were used to study the binding of integrins to laminin. The expression of laminins
in the carcinoma-cell grafts grown in the subcutaneous tissue of nude mice was
also examined.
The distribution of integrins appears to change during organ development and
maturation. Integrins α3, αv, and β1 were distributed in a diffuse manner in foetal
thyroid follicular epithelium. In mature thyroid follicular epithelium, they were
present on the basal side of the cells, suggesting that their polarization takes place
during thyroid follicular cell maturation. The integrin β3 subunit was expressed
only in mature thyroid follicular epithelium, suggesting its appearance during
development.
Among laminins, the α5, β1, β2, and γ1 chains were found in the basement
membranes (BMs) of foetal and mature thyroid follicular epithelium. Laminin β2
chain expression was found to decrease during the maturation of the thyroid
follicular epithelium. In the BMs of foetal colorectal mucosal epithelium, the
laminin α3, α5, β1, β3, and γ1 chains were found. The BMs of mature colorectal
mucosal epithelium contained in addition the laminin β2 chain. Therefore, laminin
β2 chain expression appears to be especially dynamic during development. Its
expression increases or decreases during development in a tissue-specific manner.
The laminin α2 chain was detected only in the BMs around the pericryptal
fibroblasts in mature colorectal mucosa.
Type VII collagen was also found in the BMs of mature colorectal mucosal
epithelium. Laminin α3 and β3 chains were found in the BMs in the loop of Henle
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in the mature kidney tissue. Therefore, the expression of laminin-5 (α3-β3-γ2) and
type VII collagen is not restricted to squamous and stratified epithelia, but they are
expressed also in various simple epithelia. Their expression is not restricted to BMs
of epithelia which contain hemidesmosomes.
Laminin α5, β1, β2, and γ1 chains were found in BMs of renal cell carcinomas
(RCCs), whereas the laminin α5, α3, β1, β3, and γ2 chains were detected in BMs
of papillary renal carcinomas (PRCs). Laminin-5 expression separates PRCs from
RCCs, suggesting that they are separate entities.
All of the cultured RCC cell lines produced laminin α5, β1, and γ1 chains, whereas
two out of four RCC cell lines produced the laminin β2 chain. Laminin α5, β1, and
γ1 chains were detected in all RCC cell line xenografts. Laminin α3 and β3 chains
were found in three out of four and the laminin β2 chain in one out of four
xenograft tumours. These experiments showed the active role of the environment
and host factors in the production of laminins.
In the thyroid carcinomas, neoexpression of the laminin-5 chains and also other
proteins of the epithelial cell adhesion complex (VII collagen and integrin α6β4, as
well as the hemidesmosomal proteins HD1, BP 180, and BP230) took place in
distinct thyroid carcinomas. They were produced by cells presenting markers of
squamous differentiation (cytokeratin 5) and proliferative activity (Ki-67). Their
expression was associated with papillary histology, such as in renal tumours.
The laminin α1 chain, and hence laminin-1, was totally lacking from colorectal
neoplasms. Hence, laminin-1 cannot play an important role in the biology of
colorectal adenomas and carcinomas. In the BMs of colorectal adenomas, laminin
α5, α3, β1, β3, γ1, and γ2 chains, as well as type VII collagen were detected. In the
colorectal carcinomas, type VII collagen was lost, but laminin-5 was preserved in a
trimeric macromolecular form even in the invasive parts of the tumours. Colon
carcinoma cells in vitro also produced laminin-5. The integrin subunits α3, α6, β1,
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and β4 were detected in most of the carcinoma tissue samples. Cell adhesion
experiments showed that among these integrins, α3 and β1 subunits acted in
binding to laminin-5 in colon carcinoma cells. Hence, the interplay of integrin α3β1
with laminin-5 may have an active role in colorectal carcinoma cell dissemination.
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